BOUNDLESS BIO, INC. Investment Income, Interest
BOUNDLESS BIO, INC. (BOLD) reported Investment Income, Interest of $690.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-07
- BOUNDLESS BIO, INC. investment income, interest for the quarter ending 2026-06-30 was $690.00K, a 50.22% decline year-over-year.
- BOUNDLESS BIO, INC. investment income, interest for the quarter ending 2026-03-31 was $920.00K, a 41.96% decline year-over-year.
- BOUNDLESS BIO, INC. investment income, interest for the quarter ending 2025-12-31 was $1.12M, a 41.67% decline year-over-year.
- BOUNDLESS BIO, INC. investment income, interest for the quarter ending 2025-09-30 was $1.27M, a 41.63% decline year-over-year.
- BOUNDLESS BIO, INC. investment income, interest for fiscal 2025 was $5.36M, a 32.12% decline from fiscal 2024.
- BOUNDLESS BIO, INC. investment income, interest for fiscal 2024 was $7.89M, a 49.41% increase from fiscal 2023.
- BOUNDLESS BIO, INC. investment income, interest for fiscal 2023 was $5.28M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $690.00K 10-Q · filed 2026-08-07 | $1.61M 10-Q · filed 2026-08-07 | $2.73M derived: sum of 3 quarters · filed 2026-08-07 | $4.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $920.00K 10-Q · filed 2026-05-08 | $2.04M derived: sum of 2 quarters · filed 2026-05-08 | $3.31M derived: sum of 3 quarters · filed 2026-05-08 | $4.69M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.39M derived: sum of 2 quarters · filed 2026-03-09 | $3.77M derived: sum of 3 quarters · filed 2026-08-07 | $5.36M 10-K · filed 2026-03-09 |
| 2025-09-30 | $1.27M 10-Q · filed 2025-11-05 | $2.65M derived: sum of 2 quarters · filed 2026-08-07 | $4.24M 10-Q · filed 2025-11-05 | $6.16M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.39M 10-Q · filed 2026-08-07 | $2.97M 10-Q · filed 2026-08-07 | $4.89M derived: sum of 3 quarters · filed 2026-08-07 | $7.06M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $1.58M 10-Q · filed 2026-05-08 | $3.50M derived: sum of 2 quarters · filed 2026-05-08 | $5.67M derived: sum of 3 quarters · filed 2026-05-08 | $8.06M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $4.09M derived: sum of 2 quarters · filed 2026-03-09 | $6.47M derived: sum of 3 quarters · filed 2026-03-09 | $7.89M 10-K · filed 2026-03-09 |
| 2024-09-30 | $2.17M 10-Q · filed 2025-11-05 | $4.56M derived: sum of 2 quarters · filed 2025-11-05 | $5.98M 10-Q · filed 2025-11-05 | $7.60M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $2.38M 10-Q · filed 2025-08-05 | $3.80M 10-Q · filed 2025-08-05 | $5.42M derived: sum of 3 quarters · filed 2025-08-05 | $7.17M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $1.42M 10-Q · filed 2025-05-09 | $3.04M derived: sum of 2 quarters · filed 2025-05-09 | $4.79M derived: sum of 3 quarters · filed 2025-05-09 | $6.34M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $3.37M derived: sum of 2 quarters · filed 2025-03-27 | $4.92M derived: sum of 3 quarters · filed 2025-03-27 | $5.28M 10-K · filed 2025-03-27 |
| 2023-09-30 | $1.75M 10-Q · filed 2024-11-07 | $3.30M derived: sum of 2 quarters · filed 2024-11-07 | $3.66M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $1.55M 10-Q · filed 2024-08-12 | $1.91M 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $395.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |